Peter Cicala
Directeur/Bestuurslid bij ETERNA THERAPEUTICS INC.
Actieve functies van Peter Cicala
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ETERNA THERAPEUTICS INC. | Directeur/Bestuurslid | 12-02-2024 | - |
| Independent Dir/Board Member | 12-02-2024 | - |
Loopbaan van Peter Cicala
Eerdere bekende functies van Peter Cicala
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-03-2020 | 01-03-2021 |
| CELGENE | Corporate Officer/Principal | 01-03-2014 | 01-11-2019 |
| BOUNDLESS BIO, INC. | Oprichter | 01-11-2019 | - |
Opleiding van Peter Cicala
| Seton Hall University School of Law | Graduate Degree |
| Fairleigh Dickinson University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Beurs
- Insiders
- Peter Cicala
- Ervaring
